Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Phase II Trial of Encapsulated Rapamycin to Reduce Polyp Burden Associated with Familial Adenomatous Polyposis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 08, 2025
Melanoma Vaccines: Comparing Novel Adjuvant Treatments in High-Risk Patients.
Journal: Vaccines
Published: May 04, 2025
Results of a phase I/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer.
Journal: Human vaccines & immunotherapeutics
Published: August 21, 2024
Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trial.
Journal: Cancer treatment and research communications
Published: June 10, 2024
Utility of cell-based vaccines as cancer therapy: Systematic review and meta-analysis.
Journal: Human vaccines & immunotherapeutics
Published: March 28, 2024
The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapy.
Journal: Journal of surgical oncology
Published: January 31, 2024
Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast Cancer.
Journal: Cancer research communications
Published: August 19, 2023
Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis.
Journal: Journal for immunotherapy of cancer
Published: June 28, 2023
Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters.
Journal: Journal of surgical oncology
Published: May 02, 2023
The most likely but largely ignored triggering factor for breast (or all) cancer invasion.
Journal: Journal of Cancer
Published: December 31, 2022
Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials.
Journal: Frontiers in immunology
Published: November 05, 2022
Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: August 29, 2022
Last Updated: 09/26/2026